R F Lamont1, E Havutcu, S Salgia, P Adinkra, R Nicholl. 1. Department of Obstetrics & Gynaecology, Northwick Park & St Mark's NHS Trust, Harrow, Middlesex, UK. pauline.mills@nwlh.nhs.uk
Abstract
OBJECTIVES: To determine the prevalence of and the association between trisomy 21 and isolated fetal echogenic cardiac foci (FECF) identified in the second trimester in an unselected low-risk population. METHODS: All cases with isolated FECF were collected by reviewing the antenatal ultrasound database for 3 consecutive years. In order to include all trisomy 21 cases for the same period, the regional cytogenetics database and pediatric databases were examined. A 2 x 2-table analysis was performed to establish the sensitivity, specificity and positive and negative predictive values of isolated FECF as a screening test for trisomy 21 in a low-risk unselected population. RESULTS: In the 3-year period of the study the total number of deliveries was 11,105, of which 10,769 (97%) had a routine detailed anomaly scan between 16 and 24 weeks' gestation. There were 311 cases (2.9%) of isolated FECF. Among these there was only one case (0.3%) of trisomy 21. In the same period, the total number of trisomy 21 cases was 14. Accordingly, the sensitivity of isolated FECF for detecting trisomy 21 was 7.1% and the specificity was 97.1%. Positive and negative predictive values of FECF were 0.3% and 99.9%, respectively. CONCLUSION: In an otherwise healthy pregnancy, the finding of isolated FECF on a routine second-trimester anomaly scan is normal and should not be considered as a risk factor for trisomy 21 in an unselected low-risk population. Copyright 2004 ISUOG.
OBJECTIVES: To determine the prevalence of and the association between trisomy 21 and isolated fetal echogenic cardiac foci (FECF) identified in the second trimester in an unselected low-risk population. METHODS: All cases with isolated FECF were collected by reviewing the antenatal ultrasound database for 3 consecutive years. In order to include all trisomy 21 cases for the same period, the regional cytogenetics database and pediatric databases were examined. A 2 x 2-table analysis was performed to establish the sensitivity, specificity and positive and negative predictive values of isolated FECF as a screening test for trisomy 21 in a low-risk unselected population. RESULTS: In the 3-year period of the study the total number of deliveries was 11,105, of which 10,769 (97%) had a routine detailed anomaly scan between 16 and 24 weeks' gestation. There were 311 cases (2.9%) of isolated FECF. Among these there was only one case (0.3%) of trisomy 21. In the same period, the total number of trisomy 21 cases was 14. Accordingly, the sensitivity of isolated FECF for detecting trisomy 21 was 7.1% and the specificity was 97.1%. Positive and negative predictive values of FECF were 0.3% and 99.9%, respectively. CONCLUSION: In an otherwise healthy pregnancy, the finding of isolated FECF on a routine second-trimester anomaly scan is normal and should not be considered as a risk factor for trisomy 21 in an unselected low-risk population. Copyright 2004 ISUOG.
Authors: Lisa Hurt; Melissa Wright; Frank Dunstan; Susan Thomas; Fiona Brook; Susan Morris; David Tucker; Marilyn Ann Wills; Colin Davies; Gareth John; David Fone; Shantini Paranjothy Journal: Prenat Diagn Date: 2015-11-20 Impact factor: 3.050
Authors: Lisa Hurt; Melissa Wright; Fiona Brook; Susan Thomas; Frank Dunstan; David Fone; Gareth John; Sue Morris; David Tucker; Marilyn Ann Wills; Lyn Chitty; Colin Davies; Shantini Paranjothy Journal: BMC Pregnancy Childbirth Date: 2014-05-08 Impact factor: 3.007